AIP and catecholaminergic polymorphic ventricular tachycardia: AAV-GFP-AIP delivery also suppressed abnormal Ca2+ release events in induced pluripotent stem cells derived from two patients with two distinct CPVT pathogenic mutations (Bezzerides et al., 2019).